title: The σ(1) receptor antagonist S1RA is a promising candidate for the treatment of neurogenic pain.
authors.affiliation: Institut für Pharmazeutische und Medizinische Chemie der Westfälischen Wilhelms-Universität Münster, Hittorfstrasse 58-62, D-48149 Münster, Germany. wuensch@uni-muenster.de
authors.forename: Bernhard
authors.initials: B
authors.lastname: Wünsch
mesh_terms: D000818:Animals; D005260:Female; D006801:Humans; D008297:Male; D009025:Morpholines / Q000138:chemical synthesis*; D011720:Pyrazoles / Q000138:chemical synthesis*; D017480:Receptors, sigma / Q000037:antagonists & inhibitors*; D000097605:Sigma-1 Receptor
chemical_list: D009025:Morpholines; D011720:Pyrazoles; D017480:Receptors, sigma; D000097605:Sigma-1 Receptor; C576663:4-(2-((5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine